Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
University of Aarhus |
---|---|
Information provided by: | University of Aarhus |
ClinicalTrials.gov Identifier: | NCT00203554 |
The purpose of this study is to compare the effect of vertebroplasty with that of traditional medical treatment in the treatment of painful vertebral fractures in osteoporotic patients.
Condition | Intervention |
---|---|
Pain Osteoporosis Fracture |
Genetic: Poly methylmetacrylate, PMMA |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Open Label, Active Control, Parallel Assignment, Safety/Efficacy Study |
Official Title: | Percutaneous Vertebroplasty Versus Conservative Treatment of Pain: A Prospective, Randomized Controlled Study of Osteoporotic Fractures in the Spine |
Enrollment: | 27 |
Study Start Date: | March 2004 |
Study Completion Date: | January 2008 |
Primary Completion Date: | January 2008 (Final data collection date for primary outcome measure) |
In vertebroplasty a bone cement is injected in one or more fractured vertebra. The indication is pain that needs high doses of analgesics. The cement is a well known product called poly methyl metacrylate (PMMA) normally used fixate joint prosthesis. Vertebroplasty is done in local anaesthesia. The treatment was introduced in 1984 in France and today thousands of patients have been treated worldwide, but so far no randomized controlled trials have been published.
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Responsible Party: | Aarhus University Hospital ( Leif Sorensen, Cons. Neuroradiologist ) |
Study ID Numbers: | 20020306 |
Study First Received: | September 16, 2005 |
Last Updated: | March 26, 2008 |
ClinicalTrials.gov Identifier: | NCT00203554 History of Changes |
Health Authority: | Denmark: The Danish National Committee on Biomedical Research Ethics |
osteoporosis vertebra fracture pain |
percutaneous vertebroplasty polymethylmetacrylate |
Polymethyl Methacrylate Vasodilator Agents Musculoskeletal Diseases Fractures, Bone Wounds and Injuries Disorders of Environmental Origin |
Osteoporosis Bone Diseases, Metabolic Pain Cardiovascular Agents Bone Diseases |
Vasodilator Agents Physiological Effects of Drugs Fractures, Bone Wounds and Injuries Antimutagenic Agents Osteoporosis Disorders of Environmental Origin Bone Diseases, Metabolic |
Cardiovascular Agents Protective Agents Bone Diseases Pharmacologic Actions Polymethyl Methacrylate Musculoskeletal Diseases Therapeutic Uses |